Atlas Trials

Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy

Clinical trial NCT07205536 · RECRUITING

Trial details

NCT number
NCT07205536
Sponsor
Affiliated Hospital of Nantong University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
MyelosuppressionThoracic NeoplasmsChemoradiotherapy
Start date
2025-08-01
Primary completion
2027-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.